International Journal of Infectious Diseases · 2022 · 26 citations · 10 references
PharmacyInfectious DiseasesPharmacotherapyClinical ImmunologyInfectious Disease PharmacotherapyVirologyAntiretroviral TherapyAntiviral TherapyHuman Immunodeficiency Virus PharmacotherapyImmunocompromised Host InfectionsViral InfectionsDermatologic Adverse EventsHiv-associated ImmunosuppressionHiv-associated Opportunistic InfectionsImmunocompromised Host Infection TreatmentImmunocompromised Host ManagementViral Infection TreatmentViral Skin Infections
A patient aged 28 years who is immunocompromised and living with HIV/AIDS became infected with the monkeypox virus (MPXV). His clinical condition deteriorated for 37 days, with fever, skin lesions, and diarrhea before going to the infectious diseases department, where his severe, protracted infection was treated with tecovirimat for 14 days. His condition rapidly improved, and the skin lesions decreased, as did the MPXV loads, with no adverse events. This case indicates that tecovirimat might be effective for treating patients who are immunocompromised and are infected with MPXV.
10
Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection
Angel N. Desai, George R. Thompson, Sonja M Neumeister et al. · JAMA · 2022 · 145 citations · Full text
Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12
Jesse O’Shea, Thomas D. Filardo, Sapna Bamrah Morris et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 130 citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +11
Sophie Duraffour, Marı́a M. Lorenzo, Gudrun Zöller et al. · Journal of Antimicrobial Chemotherapy · 2015 · 116 citations · Full text